Immunogenicity of a two‐dose regime of varicella vaccine in children with cancers
暂无分享,去创建一个
Chi-kong Li | T. Leung | P. Chan | R. Wong | P. Chan | E. C. Hung | K. Chik | C. Mo | Raymond P. O. Wong
[1] A. Arvin,et al. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. , 2002, The New England journal of medicine.
[2] L. Mascola,et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. , 2002, JAMA.
[3] P. Chan,et al. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation , 2000, Bone Marrow Transplantation.
[4] M. Knuf,et al. Cellular immune response of a varicella vaccine following simultaneous DTaP and VZV vaccination. , 1999, Vaccine.
[5] Chi-kong Li,et al. Transfusion‐Related Immunomodulation in Chinese Children with Thalassaemia , 1997, Vox sanguinis.
[6] P. LaRussa,et al. Varicella vaccine for immunocompromised children: results of collaborative studies in the United States and Canada. , 1996, The Journal of infectious diseases.
[7] J. Gratama,et al. Identification of an unusual Fc gamma receptor IIIa (CD16) on natural killer cells in a patient with recurrent infections. , 1996, Blood.
[8] M. Levin,et al. Varicella zoster virus-specific cytotoxicity following secondary immunization with live or killed vaccine. , 1996, Viral immunology.
[9] M. Halloran,et al. Cost-effectiveness of a routine varicella vaccination program for US children. , 1994, JAMA.
[10] A. Arvin. Cell-mediated immunity to varicella-zoster virus. , 1992, The Journal of infectious diseases.
[11] B T Grenfell,et al. The epidemiology of varicella–zoster virus infections: a mathematical model , 1992, Epidemiology and Infection.
[12] A. Gershon. Viral vaccines of the future. , 1990, Pediatric clinics of North America.
[13] A. Gershon,et al. Live attenuated varicella vaccine: protection in healthy adults compared with leukemic children. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group. , 1990, The Journal of infectious diseases.
[14] J L Sullivan,et al. Severe herpesvirus infections in an adolescent without natural killer cells. , 1989, The New England journal of medicine.
[15] E. Hunter,et al. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine. , 1989, Journal of Immunology.
[16] D. Miller,et al. Cooperation between CD16(Leu-11b)+ NK cells and HLA-DR+ cells in natural killing of herpesvirus-infected fibroblasts. , 1987, Journal of immunology.
[17] S. Feldman,et al. Varicella in children with cancer: impact of antiviral therapy and prophylaxis. , 1987, Pediatrics.
[18] R. A. Coward,et al. Severe haemorrhage from a lumbar artery as a complication of percutaneous renal biopsy. , 1985, Postgraduate medical journal.
[19] H. Holtmann,et al. Active immunization against varicella of children with acute leukaemia or other malignancies on maintenance chemotherapy. , 1985, Postgraduate medical journal.